Construction tech firm Linarc is offering a 21-day full-platform trial and free lifetime access to its project scheduling ...

All products and services featured are independently chosen by editors. However, StyleCaster may receive a commission on ...

A recent trial evaluates the impact of dostarlimab on ovarian cancer treatment, revealing modest benefits and no significant safety concerns with niraparib.

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel ...